http://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Podcast Hero Banner3gk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Online Program Plannergk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/AAAS Fellows Bannergk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Read New JMBE Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
23-01-2017mSphere Direct
23-01-2017Podcast banner
23-01-2017AAAS Fellows
23-01-2017Read new JMBE
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreats Meeting
REGISTER

Antimicrobial Chemotherapy
Division A is concerned with the discovery, mode of action, development and use of antimicrobial agents, and the mechanisms by which infective agents develop resistance to these compounds.

2013 Officers - all terms run from July 1, 2012 to June 30, 2013

Chair
Hanna M. Wexler
UCLA School of Medicine
Los Angeles, CA
hwexler@ucla.edu
310-268-3404

Chair-Elect
Jeffrey D. Alder
Bayer Healthcare Pharmaceuticals Inc.
Montville, NJ
jeff-lisa-alder@hotmail.com

Councilor
Linda A. Miller
GLAXOSMITHKLINE
Collegeville, PA
linda.a.miller@gsk.com
610-917-6280

Division A is part of Divisional Group II - Pathogenesis and Host Response Mechanisms

Divisional Group Representative
Victor DiRita
University of Michigan
Ann Arbor, MI
vdirita@umich.edu


Join DivANet

Website

 

TPL_asm2013_SEARCH

91500